Jade Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JBIO and other ETFs, options, and stocks.

About JBIO

Jade Biosciences, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. 

CEO
Tom Frohlich
CEOTom Frohlich
Employees
55
Employees55
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2018
Founded2018
Employees
55
Employees55

JBIO Key Statistics

Market cap
749.28M
Market cap749.28M
Price-Earnings ratio
-5.01
Price-Earnings ratio-5.01
Dividend yield
Dividend yield
Average volume
1.45M
Average volume1.45M
High today
$15.82
High today$15.82
Low today
$14.28
Low today$14.28
Open price
$15.10
Open price$15.10
Volume
1.60M
Volume1.60M
52 Week high
$28.00
52 Week high$28.00
52 Week low
$6.57
52 Week low$6.57

Stock Snapshot

The current Jade Biosciences(JBIO) stock price is $15.22, with a market capitalization of 749.28M. The stock trades at a price-to-earnings (P/E) ratio of -5.01.

On 2026-06-09, Jade Biosciences(JBIO) stock moved within a range of $14.28 to $15.82. With shares now at $15.22, the stock is trading +6.6% above its intraday low and -3.8% below the session's peak.

Trading volume for Jade Biosciences(JBIO) stock has reached 1.6M, versus its average volume of 1.45M.

Over the past 52 weeks, Jade Biosciences(JBIO) stock has traded between a high of $28.00 and a low of $6.57.

Over the past 52 weeks, Jade Biosciences(JBIO) stock has traded between a high of $28.00 and a low of $6.57.

JBIO News

TipRanks 5d
Jade Biosciences Launches Major Underwritten Equity Offering

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

Simply Wall St 5d
Is Jade Biosciences Fairly Priced As Shares Swing And Losses Mount?

Advertisement Jade Biosciences stock reaction Jade Biosciences (JBIO) has attracted fresh attention after recent share price swings, including a move higher i...

Is Jade Biosciences Fairly Priced As Shares Swing And Losses Mount?
TipRanks 5d
JADE101 Phase 1 Trial Marks Key Early Milestone for Jade Biosciences Investors

Jade Biosciences, Inc. (JBIO) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from anal...

Analyst ratings

100%

of 10 ratings
Buy
100%
Hold
0%
Sell
0%

More JBIO News

TipRanks 6d
Jade Biosciences announces common stock offering, no amount given

Jade Biosciences (JBIO) announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock or, in lieu of common st...

People also own

Based on the portfolios of people who own JBIO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.